Naringenin is a powerful inhibitor of SARS-CoV-2 infection in vitro
Graphical abstract
Schematic representation of TPC2 role, investigated through genetic ablation and drug blocker, in the inhibition of Coronaviruses release into the cells.
Section snippets
Naringenin was very effective in inhibiting human coronaviruses infection
Vero E6 cells were treated adding 62.5 μM Nar 1 h before infection with HCoVOC43 and HCoV229E (MOI:0.01). End-point RT/PCR results indicated a strong inhibition of viral replication as shown in Fig. 1A.
TPC2, the molecular target of Naringenin, was critical in regulating HCoV229E infection mechanism
To further assess the involvement of TPC2 in CoV infection we silenced its expression in the human cell line Huh7.5. Cells were pretreated for siRNA-mediated knockdown of TPC2, which was followed by infection with HCoV229E (MOI:0.01). Inhibition of viral replication was determined at 24, 48 and 72 h post-infection (hpi). Partial inhibition of 229E replication was observed at 24 hpi in cells silenced for TPC2 by siRNA while stronger inhibition was observed at 48 and 72 hpi (Fig. 1B). Fig. 1C
Naringenin showed a strong antiviral activity against SARS-CoV-2
Vero E6 cells were infected with SARS-CoV-2 (MOI:0.01) and monitored for the presence of cytopathic effect (CPE) at 48 and 72 hpi. Upon addition of Nar to the external medium, we observed that SARS-CoV-2 infection was inhibited in a time- and concentration-dependent manner (Fig. 1D-E). Images showed that Nar treatment did not cause toxicity on uninfected cells at any of the tested concentrations and DMSO (vehicle) did not significantly affect SARS-CoV-2 replication (Fig. 1D-E). Of note, results
Declaration of Competing Interest
The authors report no declarations of interest
Acknowledgements
This work was supported by a grant to G.A. from the Italian Ministry of Health: COVID-19 A.F. 2020-2021 N. COVID-2020-12371817.
References (19)
- et al.
Candidate drugs against SARS-CoV-2 and COVID-19
Pharmacol. Res.
(2020) - et al.
A perspective on the modulation of plant and animal two pore channels (TPCs) by the flavonoid naringenin
Biophys. Chem.
(2019) - et al.
Could an endo-lysosomal ion channel be the Achilles heel of SARS-CoV2?
Cell Calcium
(2020) - et al.
Two-pore channels as master regulators of membrane trafficking and endocytic well-being
Curr. Opin. Physiol.
(2020) - et al.
NAADP-dependent Ca2+ signaling regulates Middle East respiratory syndrome-coronavirus pseudovirus translocation through the endolysosomal system
Cell Calcium
(2018) - et al.
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2
Nature
(2020) - et al.
Could the Inhibition of Endo-Lysosomal Two-Pore Channels (TPCs) by the Natural Flavonoid Naringenin Represent an Option to Fight SARS-CoV-2 Infection?
Front. Microbiol.
(2020) - et al.
Naringenin impairs two-pore channel 2 activity and inhibits VEGF-Induced angiogenesis
Sci. Rep.
(2017) - et al.
Endocytic uptake of SARS-CoV-2: the critical roles of pH, Ca2+ and NAADP
Function
(2020)
Cited by (92)
Targeting SARS-CoV-2 entry processes: The promising potential and future of host-targeted small-molecule inhibitors
2024, European Journal of Medicinal ChemistryFine-tuning of p-coumaric acid synthesis to increase (2S)-naringenin production in yeast
2023, Metabolic EngineeringProtein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics
2023, Molecular Aspects of MedicineCitation Excerpt :Sigma-1 receptor (sigma non-opioid intracellular receptor 1) is an important factor associated with the mortality of COVID-19 patients (Lehrer and Rheinstein, 2021) several inhibitors have been predicted to be anti-COVID-19 e.g. Haloperidol, PD-144418, clemastine, Cloperastine, and progesterone. Naringenin, targeting the endo-lysosomal Two-Pore Channels (TPCs) has been shown as having anti-SARS-CoV-2 activity (Clementi et al., 2021). Dihydroorotate dehydrogenase (mitochondrial DHODH), is a Dihydroorotate oxidase involved in pyrimidine synthesis within cells.
Structurally characterized copper complexes of flavonoid naringenin with enhanced radical scavenging activity
2023, Inorganica Chimica Acta
- 1
Both authors contributed equally to this manuscript.
- 2
Both authors contributed equally to this manuscript.
- 3
G.A., M.C., A.C. and A.F. jointly share senior authorship.